NYSE:PEG
NYSE:PEGIntegrated Utilities

How Investors Are Reacting To Public Service Enterprise Group (PEG) Topping J.D. Power Utility Rankings

Recently, Public Service Enterprise Group’s subsidiaries PSEG Long Island and Public Service Electric & Gas were ranked first and second in the J.D. Power 2025 Electric Utility Business Customer Satisfaction Study for large business customers in the East. This recognition reinforces the group’s long-running efforts to improve service quality and strengthens its reputation with both regulators and commercial clients. We’ll now examine how this top-tier customer satisfaction performance may...
NasdaqGS:IRBT
NasdaqGS:IRBTConsumer Durables

iRobot (IRBT): Valuation Check After Chapter 11 Filing and Nasdaq Delisting Decision

iRobot (IRBT) just hit two major turning points at once: a voluntary Chapter 11 filing and a Nasdaq delisting notice, effectively signaling the endgame for its public equity story. See our latest analysis for iRobot. Those Chapter 11 and delisting headlines basically crystallise what the share price had been hinting at for a while. A 1 year total shareholder return of around minus 91 percent and multi year losses show that momentum has not just faded; it has largely evaporated, as equity...
NasdaqGS:DLTH
NasdaqGS:DLTHSpecialty Retail

Duluth Holdings (DLTH) Q3: Loss Narrows to -$0.29 EPS, Testing Persistent Bearish Narratives

Duluth Holdings (DLTH) has just posted Q3 2026 results with revenue of $114.9 million and basic EPS of -$0.29, as investors continue to watch how its top line and per share losses evolve. The company has seen quarterly revenue move from $127.1 million in Q3 2025 to $114.9 million in Q3 2026, while basic EPS shifted from -$0.85 to -$0.29 over the same period. This sets the stage for a closer look at how stubborn losses are shaping margins and sentiment. See our full analysis for Duluth...
NasdaqGS:OKTA
NasdaqGS:OKTAIT

Is Okta’s Recent Rally Justified After Refocusing on Identity and Access Management?

If you are wondering whether Okta is genuinely a comeback story or just another pricey growth name in cybersecurity, you are not alone. It is exactly the kind of setup where valuation really matters. After a bumpy few years, the stock has climbed to around $90.59, with a 3.2% gain over the last week, 7.9% over the past month, and 14.9% year to date, even though the 5 year return is still down 68.3%. Recent headlines have focused on Okta tightening its focus on identity and access management...
NYSE:CSTM
NYSE:CSTMMetals and Mining

Constellium (CSTM) Is Up 6.5% After Singen Battery-Foil Expansion With Solar Upgrade Has The Bull Case Changed?

Constellium SE has completed and inaugurated new finishing lines at its Singen plant in Germany, finalizing a €30 million investment with Lotte Infracell to supply high-quality aluminum foilstock for battery applications in Europe. The project not only broadens Constellium’s exposure to the European battery supply chain but also strengthens its ESG profile through on-site solar power generation and enhanced safety infrastructure. We’ll now examine how this Singen battery-foil expansion, with...
NasdaqGS:REGN
NasdaqGS:REGNBiotechs

Is Regeneron Still Attractively Priced After Its Recent Share Price Surge?

If you are wondering whether Regeneron Pharmaceuticals is still worth considering after its big run, or if most of the upside is already reflected in the price, this breakdown outlines where the potential value may be found. The stock has climbed 7.8% over the last week and 7.6% over the last month, reaching about $746.36, while longer-term returns sit at 4.4% year to date and 53.1% over five years. Recent attention has focused on Regeneron's expanding pipeline and its position in high-value...
NYSE:MAIN
NYSE:MAINCapital Markets

Main Street Capital (MAIN): Reassessing Valuation After a Recent Pullback in the Share Price

Main Street Capital (MAIN) has quietly pulled back about 3 % over the past week even as its one year total return sits near 17 %. That gap is where the opportunity gets interesting. See our latest analysis for Main Street Capital. The 7 day share price pullback sits against a modest year to date share price gain and a much stronger one year total shareholder return, suggesting short term nerves but still healthy long term momentum as income focused investors stick with the story. If MAIN has...
NasdaqGS:WDC
NasdaqGS:WDCTech

Is Western Digital’s Nasdaq 100 Inclusion Reframing The AI Storage Investment Case For WDC?

Earlier in December, Nasdaq announced that Western Digital would join the Nasdaq 100 index, reflecting the company’s growing role in large‑cap technology hardware and infrastructure. This index inclusion follows Western Digital’s post-separation focus on hard disk drives, AI-driven data center demand, and expansion into quantum computing-related technologies. We’ll now examine how Western Digital’s addition to the Nasdaq 100 potentially reshapes its AI-focused storage investment narrative...
NasdaqGS:ICUI
NasdaqGS:ICUIMedical Equipment

How Slowing Sales and Cash Strain Could Impact ICU Medical’s (ICUI) Investment Story

Recently, investors learned that ICU Medical’s annualized revenue growth over the last two years has slowed to 2.1%, while analysts now project a 7.7% revenue decline over the next 12 months amid softer demand. At the same time, a steep drop in the company’s free cash flow margin over the past five years points to rising capital needs and increasing financial strain on the business. Next, we’ll examine how concerns over slowing revenue growth could reshape ICU Medical’s previously more...
NasdaqGM:INOD
NasdaqGM:INODProfessional Services

Innodata (INOD): Evaluating Valuation as Generative AI and Federal Defense Growth Strengthen Fundamentals

Innodata (INOD) is leaning hard into its new role as a generative AI data engineering partner, and the early payoff is showing up in both its expanding tech relationships and improving profitability metrics. See our latest analysis for Innodata. The buzz around Innodata’s new generative AI and federal defense work comes against a choppier backdrop, with a 1 year total shareholder return of 35.08 percent but a weaker recent share price trend that suggests momentum is cooling after a powerful...
NYSE:EW
NYSE:EWMedical Equipment

Edwards Lifesciences (EW): Reassessing Valuation After Strong Sales Growth and Upgraded Guidance

Edwards Lifesciences (EW) is back in the spotlight after upbeat commentary around its latest earnings call, stronger sales growth, and raised guidance, a combination that often reshapes how investors think about long term upside and risk. See our latest analysis for Edwards Lifesciences. At around $85.32, Edwards Lifesciences has enjoyed a 90 day share price return of 13.46 percent and a 1 year total shareholder return of 15.11 percent, suggesting momentum is building as investors warm to its...
NasdaqGS:PHAT
NasdaqGS:PHATPharmaceuticals

Assessing Phathom Pharmaceuticals (PHAT) Valuation After Bullish Rating, Earnings Beat, Raised Guidance and VOQUEZNA Trial Progress

Phathom Pharmaceuticals stock reacts to upbeat earnings and new trial progress Phathom Pharmaceuticals (PHAT) grabbed investor attention after a bullish new analyst rating landed alongside quarterly results that beat forecasts, a raised 2025 revenue outlook, and fresh clinical progress for VOQUEZNA. See our latest analysis for Phathom Pharmaceuticals. Those upbeat earnings, stronger VOQUEZNA narrative, and the new Strong Buy call appear to be feeding into a powerful trend, with a roughly 108...
NYSE:AR
NYSE:AROil and Gas

Antero Resources (AR): Assessing Valuation After Recent Share Price Pullback and Ongoing Earnings Growth

Antero Resources (AR) has been drifting lower over the past week, even though its underlying business continues to grow revenue and earnings at a healthy clip. That disconnect is what makes the stock interesting right now. See our latest analysis for Antero Resources. The recent pullback, including a 1 week share price return of negative 11.03 percent and a year to date share price return of negative 6.58 percent at 33.23 dollars, contrasts with a resilient 1 year total shareholder return of...
NYSE:IBM
NYSE:IBMIT

Is It Too Late to Consider IBM After Its Big Hybrid Cloud and AI Driven Rally?

If you are wondering whether International Business Machines is still a value play after its big run up, or if you would just be buying into yesterday's story, this breakdown is designed to cut through the noise for you. Even after a slight pullback of 2.4% over the last week and a modest 0.8% dip over the past month, IBM is still up 37.8% year to date and 35.8% over the last year, with gains of 139.4% over 3 years and 215.8% over 5 years. Behind these moves, IBM has been in the headlines...
NYSE:RSG
NYSE:RSGCommercial Services

Republic Services (RSG): Assessing Valuation After a Recent Pullback in This Long-Term Compounder

Republic Services (RSG) has quietly kept compounding value for shareholders, and its recent pullback from highs is giving investors a fresh chance to reassess the waste management leader’s growth and income profile. See our latest analysis for Republic Services. Over the past year, Republic’s steady operations have been reflected in a respectable year to date share price return of about 7 percent. Its three year total shareholder return of roughly 71 percent shows that long term compounding...
OTCPK:FNMA
OTCPK:FNMADiversified Financial

Is Fannie Mae (FNMA) Mispriced After a 300% One-Year Surge? A Fresh Look at Its Valuation

Federal National Mortgage Association (FNMA) has quietly turned in a mixed performance lately, with the stock slipping about 9% over the past week but still up nearly 19% this month and more than tripling over the past year. See our latest analysis for Federal National Mortgage Association. With the share price now at $10.85 after a sharp 1 month share price return and a standout 1 year total shareholder return of more than 300 percent, momentum still looks constructive even though the 3...
NYSE:ATO
NYSE:ATOGas Utilities

Will Mixed Analyst Views Amid Rising EPS and Dividends Change Atmos Energy's (ATO) Narrative?

Morgan Stanley recently downgraded Atmos Energy to an Equal-Weight rating even as the company posted strong fiscal 2025 earnings per diluted share of US$7.46 and extended its decades-long streak of dividend increases. Atmos also outlined higher capital spending and constructive 2026 earnings guidance, underscoring how regulatory support and infrastructure investment are shaping its long-term profile despite mixed analyst sentiment. We’ll now examine how Atmos’s robust EPS growth and higher...
NYSE:JOE
NYSE:JOEReal Estate

Should a New Publix-Anchored Center Shift How Investors View St. Joe's (JOE) Retail Strategy?

The St. Joe Company recently began developing a Publix Super Market at its Watersound West Bay Center in Panama City Beach, planning a 50,000-square-foot store with pharmacy, deli, bakery and adjacent liquor store alongside additional leasable retail space. This project deepens St. Joe’s commercial leasing base while tying its retail footprint directly to the growing Latitude Margaritaville Watersound and Ward Creek residential communities along the State Road 79 corridor. We’ll now look at...
NYSE:NLY
NYSE:NLYMortgage REITs

Annaly Capital Management (NLY): Assessing Valuation After Announcing Its Q4 2025 Cash Dividend

Annaly Capital Management (NLY) just declared a fourth quarter 2025 cash dividend of $0.70 per share, payable on January 30, 2026, with both the record date and ex dividend date set for December 31, 2025. See our latest analysis for Annaly Capital Management. At a share price of $22.12, Annaly’s roughly 20 percent year to date share price return and 30 percent one year total shareholder return suggest momentum is still positive as investors continue to reward its income profile despite...
NasdaqGS:TER
NasdaqGS:TERSemiconductor

Is It Too Late To Consider Teradyne After Its 2025 AI and Automation Rally?

If you are wondering whether Teradyne is still worth buying after its big run, or if you might be late to the party, you are in the right place to unpack what the current share price might really be saying about value. Despite a recent 3.8% pullback over the last week, the stock is still up 13.1% over the past month, 51.9% year to date, and 50.9% over the last year. This naturally raises questions about whether expectations have run ahead of fundamentals. Over the past few months, investors...
NasdaqGS:IPAR
NasdaqGS:IPARPersonal Products

CEO’s $25,000 Share Purchase Might Change The Case For Investing In Inter Parfums (IPAR)

Inter Parfums’ Chairman and CEO Jean Madar recently bought 25,000 company shares, according to a regulatory filing made on 15 December 2025. This sizeable insider purchase highlights management’s willingness to commit personal capital, which many investors view as a meaningful signal of confidence. We’ll now explore how this insider buying supports Inter Parfums’ asset-light, digitally focused growth narrative and what it might mean for investors. Rare earth metals are the new gold rush...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

How Meta’s AI, Clean-Energy Deals and Smart Glasses Push (META) Has Changed Its Investment Story

In recent days, ACES Pest Control announced a company-wide rollout of Meta Smart Glasses for field technicians in New Zealand, while Meta and NextEra Energy Resources reached about 2.5 gigawatts of clean-energy contracts to support Meta’s operations across multiple US power markets. Together with Meta’s new dividend, fresh AI product launches, and mounting regulatory and advertising scrutiny, these developments highlight how the company is simultaneously scaling infrastructure, expanding use...
NYSE:TDC
NYSE:TDCSoftware

Is Teradata’s Cloud Pivot Creating a 2025 Value Opportunity After Recent Share Price Pullback?

Wondering if Teradata is quietly turning into a value opportunity, or if the market is rightly cautious at around $29.68? This breakdown will help you decide whether the current price really makes sense. The stock has slipped about 5.5% over the last week but is still up roughly 9.0% over the past month, leaving shares down 3.2% year to date and about 9.5% lower over the last year. This pattern hints at shifting sentiment rather than a clear trend. Recently, the market has been reacting to...
NasdaqGM:MIRM
NasdaqGM:MIRMBiotechs

Mirum Pharmaceuticals (MIRM): Assessing Valuation After Strong Multi‑Year Shareholder Returns

Mirum Pharmaceuticals (MIRM) has quietly turned into one of those stocks that reward patience, with shares up roughly 57% over the past year even after some recent month level volatility. See our latest analysis for Mirum Pharmaceuticals. The latest moves fit into a broader uptrend, with Mirum’s 1 day share price return of 4.6 percent and strong year to date share price gains. These build on an impressive multi year total shareholder return profile. If Mirum’s run has you thinking about what...